JOINN LABORATORIES — BEIJING
To offer our clients versatility with our bioanalytical services, Nexelis formed a strategic partnership with JOINN laboratories, located in the hub of the biopharmaceutical sector of China in Beijing.
Expanding our global footprint into China supports international vaccine sponsors while advancing the footprint of our vaccine specialty lab testing capabilities and allowing Nexelis to provide comprehensive drug development capabilities worldwide.
Performing our bioanalytical testing under Nexelis’ procedures and methods, this state-of-the-art lab provides superior scientific expertise from more than 600 staff members to provide the support you need for your global clinical trials, while meeting the Nexelis standards of timeliness and excellence.
JOINN Beijing is a 13,000 square meter (140,000 square foot) facility with an 8,100 square meter (87,000 square foot) area dedicated to animal facilities. This includes conventional animal holding, specific pathogen-free (SPF), and BSL-2.
These laboratories are National Medical Product Administration (NMPA), U.S. Food and Drug Administration (FDA), Organisation for Economic Co-operation and Development (OECD), and Korean Ministry of Food and Drug Safety (MFDS) inspected for GLP compliance, as well as being AAALAC accredited. JOINN Beijing has an excellent 20+ year track record and it is the first Chinese CRO to be inspected by the U.S. FDA for GLP compliance and certified by the NMPA.
This lab was founded in 1995 and is located in the Beijing Economic and Development Area (Yizhuang). JOINN’s Beijing lab is a leading preclinical studies CRO. It has doubled its drug development molecule evaluations over the past five years — bringing its total to more than 1,400 compounds — and has presented more than 130 applications to the U.S. FDA.